Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Viking Thera (NQ: VKTX ) 49.84 -7.16 (-12.56%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 17, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 6,437,103 Open 53.69 Bid (Size) 50.76 (9) Ask (Size) 51.00 (1) Prev. Close 57.00 Today's Range 48.26 - 53.78 52wk Range 8.280 - 99.41 Shares Outstanding 99,581,693 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News Why ASLAN Pharmaceuticals Shares Are Trading Lower By Over 38%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session Today 13:28 EDT Via Benzinga Obesity-Drugs Focused Stocks Tumble On Wednesday - What's Going On With Eli Lilly, Novo Nordisk, Viking Therapeutics, Structure Therapeutics? Today 10:47 EDT Eli Lilly, Novo Nordisk, Viking Therapeutics, and Structure Therapeutics shares are down following Roche's promising CT-996 trial results for type 2 diabetes and obesity. Get insights into the latest... Via Benzinga Performance YTD +172.65% +172.65% 1 Month -4.19% -4.19% 3 Month -25.02% -25.02% 6 Month +132.68% +132.68% 1 Year +223.43% +223.43% More News Read More Jim Cramer Says Don't Sell Match Group: 'You've Just Got A Very, Very Smart Investor In There' Today 8:55 EDT Via Benzinga Spotlight on Viking Therapeutics: Analyzing the Surge in Options Activity July 05, 2024 Via Benzinga Here's How Much $1000 Invested In Viking Therapeutics 5 Years Ago Would Be Worth Today July 01, 2024 Via Benzinga Eli Lilly, Novo Nordisk Fall As Roche Releases Weight-Loss Drug Data Today 8:13 EDT Via Investor's Business Daily Is Viking Therapeutics the Best Biotech Stock for You? Today 7:25 EDT Via The Motley Fool The 3 Most Undervalued Biotech Stocks to Buy in July 2024 July 12, 2024 Via InvestorPlace Is Viking Therapeutics Stock Running Out of Steam? July 11, 2024 Via The Motley Fool Better GLP-1 Biotech Stock: Altimmune vs. Viking Therapeutics July 10, 2024 Via The Motley Fool Eli Lilly Stock Leads in GLP-1 Race with its Triple Agonist Drug July 09, 2024 Via MarketBeat Eli Lilly Rose More Than 50% So Far This Year. Can It Soar Past $1,000 in the 2nd Half? July 09, 2024 Via The Motley Fool 3 Overlooked Giants-in-the-Making for Patient Investors July 08, 2024 Via InvestorPlace The 7 Best Under $10 Stocks to Buy in July 2024 July 06, 2024 Via InvestorPlace Forget Eli Lilly: 3 Biotech Stocks to Buy Instead July 04, 2024 Via The Motley Fool S&P 500, Nasdaq 100 Climb To Record Highs As Data Fosters Rate Cut Optimism Ahead Of Fed Minutes; Gold, Bonds Rally: What's Driving Markets Wednesday? July 03, 2024 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities 3 Biotech Moonshots With Imminent Catalyst Potential July 03, 2024 Via InvestorPlace Altimmune Stock: Is Its GLP-1 Drug the Next Ozempic Killer? July 03, 2024 Via MarketBeat Exposures Product Safety Pfizer Stock is Ready to Stage a Turnaround on GLP-1 Hopes July 02, 2024 Via MarketBeat Eli Lilly Stock Up: GLP-1 Zepbound Targets Sleep Apnea Market July 01, 2024 Via MarketBeat Exposures Product Safety Viking Therapeutics Stock Is Up by 154% Since January -- Can It Double Again in the Second Half of the Year? July 01, 2024 Via The Motley Fool 3 Reasons Why Altimmune Stock Could Be the Next Viking Therapeutics June 30, 2024 Via The Motley Fool The 3 Smartest Biotech Stocks to Buy With $5K Right Now June 28, 2024 Via InvestorPlace The Top 3 Weight Loss Drug Stocks to Buy for Huge Gains June 28, 2024 Via InvestorPlace Prediction: These Could Be the Best-Performing Healthcare Stocks Through 2030 June 28, 2024 Via The Motley Fool Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
